Advertisement
U.S. markets open in 2 hours 37 minutes

Statera Biopharma, Inc. (STAB)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
0.00010.0000 (0.00%)
At close: 03:00PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
Cost of Revenue
1,096
488.314
0
-
Gross Profit
-1,096
-488.314
0
-
Operating Expense
18,883
28,830
10,909
2,814
Operating Income
-19,980
-29,318
-10,909
-2,814
Net Non Operating Interest Income Expense
-4,690
-4,560
-1,131
-124.233
Other Income Expense
-67,188
-67,997
-580.001
-285.613
Pretax Income
-91,858
-101,875
-12,620
-3,224
Net Income Common Stockholders
-91,833
-101,851
-12,094
-3,224
Diluted NI Available to Com Stockholders
-91,833
-101,851
-12,094
-3,224
Basic EPS
-2.36
-2.90
-0.47
-0.13
Diluted EPS
-2.36
-2.90
-0.47
-0.13
Basic Average Shares
48,037
35,110
25,650
25,650
Diluted Average Shares
48,037
35,110
25,650
25,650
Total Operating Income as Reported
-88,196
-98,344
-10,502
-2,814
Total Expenses
19,980
29,318
10,909
2,814
Net Income from Continuing & Discontinued Operation
-91,833
-101,851
-12,094
-3,224
Normalized Income
-24,645
-33,854
-11,514
-3,224
Interest Expense
-
-
1,131
124.233
Net Interest Income
-4,690
-4,560
-1,131
-124.233
EBIT
-19,170
-29,318
-10,909
-2,814
EBITDA
-18,614
-29,062
-10,908
-2,814
Reconciled Cost of Revenue
1,096
488.314
0
-
Reconciled Depreciation
556.31
255.574
0.947
0
Net Income from Continuing Operation Net Minority Interest
-91,833
-101,851
-12,094
-3,224
Total Unusual Items Excluding Goodwill
-67,188
-67,997
-580.001
-
Total Unusual Items
-67,188
-67,997
-580.001
-
Normalized EBITDA
48,574
38,935
-10,328
-2,814
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0